APGE: Apogee Therapeutics Inc

APGE新闻

• 14:44 Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
• 18:00 Biotech Euphoria Driven By Fundamentals
• 23:30 AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
• 14:28 SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
• 12:56 J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?
• 15:55 U.S. Equity Markets: Lots Of Gambling Going On
• 21:20 Biotech Is The Rate Cut Trade In Disguise
• 21:00 Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)
• 15:10 Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
• 18:39 Healthcare stocks have become a haven for investors ditching tech
• 14:00 Stock Market Weekly Review: S&P 500, Nasdaq Below 50-Day Line; Micron, Apple In Focus
• 15:11 Is Kymera Therapeutics The Next Big Rival To Regeneron And Sanofi?
• 19:15 AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.
• 14:50 ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout
• 13:25 Company News for Jun 23, 2026
• 20:53 The $11 Billion Reason Abbvie Stock Is Up Today
• 20:36 Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks
• 19:46 Apogee: "Hold" On AbbVie $10.9B Buyout And Extended Half-Life IL-13 Zumilokibart For AD
• 19:03 AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE)
• 18:50 Wall Street Lunch: U.S. Authorizes Iranian Oil Sales
• 16:08 Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monda
• 15:23 Stocks Erase Early Gains as Alphabet and Software Companies Fall
• 14:11 Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks
• 13:16 AbbVie Goes On The Offensive With $10.9 Billion Takeover